Navigation Links
A ray of hope in treating blindness and other eye disorders

A recent study has focused on the communication processes between cells that could perhaps be extrapolated to prevent the spread of damaged cells, leading to blindness.

Normally cells have a blood supply to send nutrients from // one cell to the other, enabling communication. For cells that don't have that, there has to be tiny bridge like connections, which enables movement of molecules to and fro in the same way. This type of a communication network is found in cells of the eye.

What is beneficial in one way may be harmful in another way. For example, if a cell is damaged, then the damage is communicated to the neighboring cell also, thereby damaging it. The damage continues to spread, leading to severe eye damage if the gap junctions are not closed off.

If some mechanism is invented to close this channel between the cells, the damage can be restricted to the parent cell and protecting the rest. Research is currently being done to develop a chemical that would stop the spread of damaged cells. The main concern for scientists in the process of injecting the chemical into the eye is to do so without damaging the retina.

The blood brain barrier, which restricts the certain drugs or other substances from reaching the brain and eye, poses serious technical difficulties. If this difficulty were overcome, the treating eye disorder would be made all the more simple.
'"/>




Page: 1

Related medicine news :

1. Gene Therapy shows promise in treating Hemophilia
2. Ketoconazole 2% more effective in treating Seborrheic Dermatitis
3. Diuretics are better for treating blood pressure problems than newer medicines
4. Child Friendly Zidovudine Preparation for treating HIV infection Approved By The FDA
5. Surgeons in India to Mend ‘Pakistani Hearts’ by treating 70 Childrn
6. Weight reduction by 5% may help in treating nonalcoholic fatty liver disease
7. Lower doses of oral contraceptives helpful in treating acne
8. Systemic Corticosteroid Therapy can be used for treating all types of Infectious Mononucleosis
9. Novel Actemra monotherapy in treating patients with early aggressive rheumatoid arthritis
10. Antidepressant drugs best for treating Depression
11. Thalidomide is the new approved drug for treating multiple cancers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... March 23, 2017 , ... The TouchPoint Solution, home of ... manage stress and anxiety. , “Buzzies change the way we interact with stress ... Buzzies. , Since its launch date in December 2016, The TouchPoint Solution has sold ...
(Date:3/23/2017)... CA (PRWEB) , ... March 23, 2017 , ... ... management and workflow solutions, today named The Resource Group as their 2016 Microsoft ... and partner conference in Newport Beach, CA. The award recognizes The Resource ...
(Date:3/23/2017)... ... 23, 2017 , ... According to the National Sleep Foundation , poor ... the only cause of the sunken-eye look, which can include dark circles or bags ... poor health are likely due to genetics, dehydration, allergies, and losing fat beneath the ...
(Date:3/23/2017)... CA (PRWEB) , ... March 23, 2017 , ... ... FACIS Monthly Monitoring Healthcare products at competitive pricing. Verisys through ... sanctions, Exclusions, Debarments, License restrictions and Disciplinary actions. , “We are delighted to ...
(Date:3/23/2017)... ... March 23, 2017 , ... On 2 March ... the US Special Operations Command’s Patriot Award. The award was presented by the ... Force Dagger Foundation for its significant and enduring support to the command. ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017   Icertis , the leading ... the cloud, today announced an upgrade to the ... to improve clinical trials contract management. Built on ... the solution speeds up clinical trial contracting while ... (CRO). "The pharmaceutical industry is ...
(Date:3/23/2017)... 23, 2017  Interpace Diagnostics Group, Inc. (NASDAQ: ... integrated commercial company that provides clinically useful molecular ... it has entered into agreements to successfully restructure ... ("RedPath") and concurrently terminate its royalty and milestone ... debt to RedPath amounting to $9.34 million is ...
(Date:3/23/2017)... 2017  Additive Orthopaedics, LLC., an early stage ... kicked off a multi-centered clinical study to measure ... According to Brian McLaughlin , ... structures have already shown tremendous post-operative success and ... wedges from which we have seen evidence of ...
Breaking Medicine Technology: